Description: Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of malignant tumors, neurological, autoimmune, chronic metabolic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.
Home Page: www.junshipharma.com
Building 7, No. 6
Shanghai,
200126
China
Phone:
86 21 6105 8800
Officers
| Name | Title |
|---|---|
| Mr. Jun Xiong | Executive Chairman |
| Mr. Cong Li | Co-CEO & Executive Director |
| Dr. Jianjun Zou M.D., Ph.D. | GM, CEO & Executive Director |
| Dr. Ning Li M.D., Ph.D. | Executive Vice-Chairman of the Board |
| Mr. Baohong Xu | Financial Director |
| Mr. Zhuobing Zhang | Deputy GM & Executive Director |
| Dr. Sheng Yao Ph.D. | Senior VP & Executive Director |
| Dr. Gang Wang | Deputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director |
| Dr. Xin Li | Executive Director |
| Ms. Lu Yuan | Assistant to GM & Chief of Internal Audit Department |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.806 |
| Price-to-Sales TTM: | 1.9077 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2568 |